BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tu J, Jia Z, Ying X, Zhang D, Li S, Tian F, Jiang G. The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma. Medicine (Baltimore) 2016;95:e5606. [PMID: 27930585 DOI: 10.1097/MD.0000000000005606] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu H, Min X, Ren Y, Yang L, Liu F. Comparative Study of Drug-eluting Beads versus Conventional Transarterial Chemoembolization for Treating Peculiar Anatomical Sites of Gastric Cancer Liver Metastasis. Med Sci Monit 2020;26:e922988. [PMID: 32474569 DOI: 10.12659/MSM.922988] [Reference Citation Analysis]
2 Roehlen N, Knoop RF, Laubner K, Seufert J, Schwacha H, Thimme R, Fischer A. Ischemic Duodenal Ulceration after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Case Report. Case Rep Gastroenterol 2018;12:352-9. [PMID: 30057519 DOI: 10.1159/000490604] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Hamada M, Ueshima E, Ishihara T, Koide Y, Okada T, Horinouchi H, Ishida J, Mayahara H, Sasaki K, Gentsu T, Sofue K, Yamaguchi M, Sasaki R, Sugimoto K, Murakami T. The feasibility of transcatheter arterial chemoembolization following radiation therapy for hepatocellular carcinoma. Acta Radiol Open 2021;10:20584601211034965. [PMID: 34394958 DOI: 10.1177/20584601211034965] [Reference Citation Analysis]
4 Zou J, Li C, Chen Y, Chen R, Xue T, Xie X, Zhang L, Ren Z. Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma. Oncol Lett 2019;18:6423-30. [PMID: 31807165 DOI: 10.3892/ol.2019.11037] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Li Y, Zhou F, Liu F, Wang M, Xing W. Experimental Study on Evaluation of Blood Supply Level and Embolization Ratio of Liver Cancer Based on I-Flow Software. Technol Cancer Res Treat 2020;19:1533033820970665. [PMID: 33174500 DOI: 10.1177/1533033820970665] [Reference Citation Analysis]
6 Alqadi MM, Khan S, Kord A, Shah KY, Gaba RC. Hypersensitivity Reaction after Transarterial Chemoembolization. Semin Intervent Radiol 2020;37:426-9. [PMID: 33041490 DOI: 10.1055/s-0040-1715869] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Son DJ, Hong JY, Kim KH, Jeong YH, Myung DS, Cho SB, Lee WS, Kang YJ, Kim JW, Joo YE. Liver abscess caused by Clostridium haemolyticum infection after transarterial chemoembolization for hepatocellular carcinoma: A case report. Medicine (Baltimore) 2018;97:e0688. [PMID: 29742715 DOI: 10.1097/MD.0000000000010688] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
8 Bai Y, Zheng Z, Du M, Yao H, Liu Y, Suo J. Bloodstream Infection and Its Clinical Characteristics and Relevant Factors Associated with Interventional Therapy in a Large Tertiary Hospital: A Six Years Surveillance Study. Biomed Res Int 2019;2019:8190475. [PMID: 31781645 DOI: 10.1155/2019/8190475] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Okay M, Çetik S, Haznedaroğlu İC. Tumor Lysis Syndrome Due to Targeting of Hepatocellular Carcinoma Associated with Chronic Myelomonocytic Leukemia. Turk J Haematol 2019;36:218-9. [PMID: 31067853 DOI: 10.4274/tjh.galenos.2019.2019.0113] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Nishida K, Lefor AK, Funabiki T. Rupture of Hepatocellular Carcinoma after Transarterial Chemoembolization followed by Massive Gastric Bleeding. Case Reports Hepatol 2018;2018:4576276. [PMID: 29974003 DOI: 10.1155/2018/4576276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Zhang TQ, Huang ZM, Shen JX, Chen GQ, Shen LJ, Ai F, Gu YK, Yao W, Zhang YY, Guo RP, Chen MS, Huang JH. Safety and effectiveness of multi-antenna microwave ablation-oriented combined therapy for large hepatocellular carcinoma. Therap Adv Gastroenterol 2019;12:1756284819862966. [PMID: 31489030 DOI: 10.1177/1756284819862966] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lan X, Xiang Y, Liu F, Li B, Wei Y, Zhang H. Massive hemoperitoneum and upper gastrointestinal hemorrhage following liver rupture secondary to gallbladder perforation: A case report and literature review. Medicine (Baltimore) 2019;98:e14729. [PMID: 30882639 DOI: 10.1097/MD.0000000000014729] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Kudo M, Finn RS, Morimoto M, Rau KM, Ikeda M, Yen CJ, Galle PR, Llovet JM, Daniele B, Lim HY, McIlwain DW, Yoshikawa R, Nakamura K, Liang K, Wang C, Abada P, Widau RC, Zhu AX. Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2). Liver Cancer 2021;10:451-60. [PMID: 34721507 DOI: 10.1159/000516605] [Reference Citation Analysis]
14 Ye T, Zhu P, Liu Z, Ren Q, Zheng C, Xia X. Liver abscess after drug-eluting bead chemoembolization in patients with metastatic hepatic tumors. Br J Radiol 2021;:20211056. [PMID: 34762523 DOI: 10.1259/bjr.20211056] [Reference Citation Analysis]
15 Papamichail M, Pizanias M, Heaton ND, M P, M P, Nd H. Minimizing the risk of small-for-size syndrome after liver surgery. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00230-7. [PMID: 34961675 DOI: 10.1016/j.hbpd.2021.12.005] [Reference Citation Analysis]
16 Aseni P, Di Domenico SL, Barbosa F, Rampoldi A, Berry C. Hemoperitoneum in cirrhotic patients in the absence of abdominal trauma. Expert Rev Gastroenterol Hepatol 2019;13:867-76. [PMID: 31204541 DOI: 10.1080/17474124.2019.1631159] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Bilbao JI, Páramo M, Madrid JM, Benito A. Hepatocellular carcinoma treatment: ablation and arterial embolization. Radiologia (Engl Ed) 2018;60:156-66. [PMID: 29108656 DOI: 10.1016/j.rx.2017.09.004] [Reference Citation Analysis]
18 Rogatko CP, Weisse C, Schwarz T, Berent AC, Diniz MA. Drug-eluting bead chemoembolization for the treatment of nonresectable hepatic carcinoma in dogs: A prospective clinical trial. J Vet Intern Med 2021;35:1487-95. [PMID: 33955600 DOI: 10.1111/jvim.16109] [Cited by in F6Publishing: 1] [Reference Citation Analysis]